NewsWhore
10-27-2009, 09:00 AM
KMDA ) has obtained approval from Brazil's National Health Surveillance Agency (Anvisa) for its Alpha-1 Antitrypsin (AAT) protein for the treatment of congenital emphysema. Kamada estimates Brazilian ...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/29132138/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/29132138/)